ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Legal News Blogs -> Law Blog - WSJ.com

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Legal News

: Law Blog - WSJ.com

Patent Lawyers Do the Boogie as Court Shoots Down PTO Rules

By Dan Slater

ADVERTISEMENTS

lawyerThe patent crowd is an excitable bunch. Whenever a big ruling is handed down, the Law Blog typically receives a few helpful e-mails from lawyers in that practice area giving us their thoughts. But this morning, we were flooded with notes from patent lawyers who could barely contain their glee over a Virginia district court’s ruling in Tafas v. Dudas.

Here’s what they’re so pumped about: The PTO was seeking to streamline the application process and unclog a backlog of patent applications by reducing the number of claims and continuations allowed in a patent application. (Claims help define a patent, while continuations are used to amend patent claims and contest rejected patent claims.) Critics of the rules, according to reports, felt that the limitations on patent claims would mean that more complex patents would lose substance.

Yesterday, in a nod to administrative law, district judge James Cacheris voided the rules because, he wrote, the PTO doesn’t have the power to make the changes. Why? He ruled the changes were substantive, not procedural. Here’s a report from The Recorder, and here’s some nice analysis from the Patently-O blog, which also provides a link to the opinion. Click here for more discussion at the Patent Prospector blog.

The rules were scheduled to go into effect last November, but Triantafyllos Tafas, founder of medical technology company Ikonisys, and drug maker GlaxoSmithKline filed lawsuits against the PTO and its director, Jon Dudas, to block them. Judge Cacheris granted a preliminary injunction on Oct. 31, and GlaxoSmithKline and Tafas filed for summary judgment on Dec. 20. In granting summary judgment Tuesday, Cacheris wrote that the patent office can’t make “substantive” changes to the rules, only “procedural” ones.

Representing Glaxo: Kirkland & Ellis’s Daniel Sean Trainor and Elizabeth Locke. Representing Tafas: Kelley Drye’s William Golden, Steven Moore and James Nealon.

“There’s a lot of good cheer going around,” Fish & Richardson’s Hans Troesch told The Recorder. “It’s a great relief to the practitioners.”

“We are disappointed with this court’s decision, which rejects our view that the USPTO has the authority to implement the proposed rules about claims and continuations,” said the PTO in a statement. “The USPTO believes that these rules are consistent with existing statutes and will strengthen the U.S. patent system for all stakeholders.”

Full post as published by Law Blog - WSJ.com on December 31, 1969 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.014 secs (new cache)